CD8A and neoplasm: Notably, while CD8+ effector cells contribute to anti-tumor immunity, the concurrent presence of Tregs may represent a balancing mechanism in the immune response, highlighting the dynamic and complex interplay between immune cell populations in shaping the immunosuppressive and immunoreactive characteristics of the TME.